AKTS has released its 2025 Q4 earnings report, with revenue of 1.87M, reflecting a YoY change of 100.43%, and net profit of -15.14M, showing a YoY change of -25.56%. The Sankey diagram below clearly presents AKTS's revenue sources and cost distribution.

Aktis Oncology (AKTS) key financial stats and ratios, covering profitability, financial health, and leverage.

Aktis Oncology (AKTS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Aktis Oncology (AKTS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Aktis Oncology (AKTS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Where does Aktis Oncology (AKTS) generate its revenue? Explore its key revenue streams and top earning regions.